The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

THEUER CHARLES

Reporting owner CIK 0001631338 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.THEUER CHARLESTHEUER CHARLESTHEUER CHARLES · December 12, 2025 · Exercise / conversion · Common StockDec 12, 2025Dec 12, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 12, 20254D Molecular Therapeutics, Inc.Common StockTHEUER CHARLESExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: 4D Molecular Therapeutics, Inc.FDMT · company listingsExercise / conversionCommon StockNon-derivative security · Code M9,3331.14Value: 10,639.62Currency not specifiedView ↗